Mustang Bio Inc. (NASDAQ: MBIO)
$0.40
+0.0041 ( +1.03% ) 1.2M
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Market Data
Open
$0.40
Previous close
$0.40
Volume
1.2M
Market cap
$13.06M
Day range
$0.39 - $0.41
52 week range
$0.13 - $5.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Dec 19, 2023 |
8-k | 8K-related | 12 | Dec 12, 2023 |
8-k | 8K-related | 14 | Dec 11, 2023 |
10-q | Quarterly Reports | 69 | Nov 14, 2023 |
8-k | 8K-related | 14 | Nov 14, 2023 |
8-k | 8K-related | 14 | Nov 02, 2023 |
8-k | 8K-related | 22 | Oct 30, 2023 |
8-k | 8K-related | 14 | Oct 26, 2023 |
8-k | 8K-related | 12 | Oct 04, 2023 |
8-k | 8K-related | 14 | Aug 16, 2023 |